MedTrace Logo

Clinical Trial Examining the Short and Long-term Effect of Myofascial Trigger Points Injection in Low Back Pain Patients

NCT01520415 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-07-29

No results posted yet for this study

Summary

The objective of this study is to examine the short and long-term effect of myofascial trigger point injections with either a local anesthetic or saline in patients with chronic low back pain presenting with myofasical pain syndrome.

Conditions

  • Low Back Pain

Interventions

DRUG

Bupivacaine

2ml per injection up to a maximum of 8ml (4 identified trigger points) per visit

DRUG

Saline

2ml per injection up to a maximum of 8ml (4 identified trigger points) per visit

Sponsors & Collaborators

  • Dr. Yoram Shir

    lead OTHER

Principal Investigators

  • Yoram Shir, MD · MUHC-RI

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-06-30
Completion
2013-07-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01520415 on ClinicalTrials.gov